August 7, 2024Open Access

Efficacy, adherence and persistence of various glucagon‐like peptide‐1 agonists: nationwide real‐life data

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The management of type 2 diabetes mellitus has advanced in the last two decades since the introduction of glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, multiple factors may interfere with achieving better glycaemic control. This study evaluated the differences between various GLP-1RAs in efficacy, adherence and persistence.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Kassem et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5d23bb6db643587567f3f https://doi.org/https://doi.org/10.1111/dom.15828

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis2024 · 486 citations
2Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review2023 · 52 citations
3Trends in Diabetes Treatment and Control in U.S. Adults, 1999–20182021 · 684 citations
4Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study.2010 · 5,414 citations
5Home visits: a strategy to improve newborn survival - Authors' reply2008 · 22,557 citations

Me gusta

Guardar

Ver artículo completo